Skip to main content
Clinical Trials/NCT01017237
NCT01017237
Terminated
Phase 4

Comparison of the Effectiveness of Sedation With i.v. Dexmedetomidine in Combination With Midazolam Alone or Midazolam and Low Dose Ketamine for Extraction of Third Molars.

University of North Carolina, Chapel Hill1 site in 1 country18 target enrollmentJuly 2009

Overview

Phase
Phase 4
Intervention
Dexmedetomidine
Conditions
Anesthesia
Sponsor
University of North Carolina, Chapel Hill
Enrollment
18
Locations
1
Primary Endpoint
Amnesia: Lack of Picture Recall Shown 15 Minutes Into Surgery
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

Intravenous sedation is used frequently for the relief of pain and anxiety associated with oral surgical procedures performed under local anesthesia. The purpose of this study is to learn about patient and surgeon satisfaction with sedation using Dexmedetomidine in combination with midazolam alone or with midazolam plus low dose ketamine while having wisdom teeth removed.

The sedation produced by dexmedetomidine is unique in that it mimics natural sleep, a unique quality not shared by other drugs. Dexmedetomidine is often used in anesthesia in hospital operating rooms and has been approved by the US Food and Drug Administration for the use planned in this study.

Detailed Description

Subjects who have been screened medically and are scheduled for third molar surgery in the University of North Carolina (UNC)Oral and Maxillofacial Surgery (OMFS) clinic will be asked to volunteer for the study by the evaluating OMFS resident or attending physician. No additional x-rays will be taken other than those usually indicated for 3rd molar surgery. Informed consent will be obtained by study investigators. Subjects will be instructed to fast for at least 8 hours prior to their appointment. Surgery will be performed in the Oral \& Maxillofacial Surgery operating/sedation clinic where all monitoring equipment as well as emergency equipment is readily available, including the ability to ventilate the patient with oxygen (bag-mask), the ability to intubate, resuscitation drugs and equipment including a defibrillator. Patients will be positioned in a semi-reclining position in the dental chair and all monitors applied. A 20 gauge i.v. catheter will be placed and normal saline infusion attached. Supplemental oxygen will be administered via nasal cannula at 3 liters per minute. A picture will then be shown for recall testing. Pulse rate, arterial oxygen saturation (SpO2), respiratory rate, blood pressure, end-tidal CO2 (ETCO2), Ramsey Sedation Score (RSS sedation score) and Bispectral Index Scale (BIS) value will be recorded as a baseline and at 5 minute intervals during the procedure. Any SpO2 values below 90% as well as any episodes of apnea greater than 20 seconds will be recorded. Monitoring and recording of all data will be done by one of the investigators. Data will be recorded on pre-printed data forms. The surgical procedure will be performed by an oral and maxillofacial surgery resident physician. Following the administration of 0.12 mg/kg of dexamethasone , dexmedetomidine will be infused at a rate of 6 mcg/kg/hr for four minutes; resulting in a loading dose of 0.4 mcg/kg. All of the above parameters will again be obtained and recorded. Patients will be randomly assigned by block randomization to receive either midazolam 0.04 mg/kg i.v. (50 patients), or midazolam 0.04 mg/kg plus 0.25 mg/kg of ketamine (50 patients). The operating surgeon and the patient will be blinded as to which protocol is being used. A dexmedetomidine infusion of 0.5 mcg/kg/hr will be initiated and continued until the completion of surgery. At this point local anesthesia will be administered in all four quadrants. Pain reaction during injections will be recorded. When efficacy of local anesthesia has been confirmed, surgery will commence. The surgery will be interrupted at 15 and 30 minutes to show a picture for recall testing by an investigator. If at any point the patient is deemed to be uncomfortable or uncooperative due to inadequate sedation, the protocol will be broken and additional sedation administered as per usual standards. The rescue therapy may include additional midazolam, ketamine, narcotic or propofol at the discretion of the anesthetist/sedationist. At the conclusion of surgery the dexmedetomidine infusion will be discontinued and the patient will be attended by a recovery nurse for collection of postoperative data. During recovery the physiologic parameters will be recorded at 10 minute intervals. When the patient achieves a recovery Aldrete score of \>9, they will be asked by an investigator to recall pictures for amnesia assessment, and asked to assess patient satisfaction before leaving with an escort. The patient will be contacted on the day following surgery by phone or e-mail by one of the investigators to test for recall of pictures shown (amnesia testing) and patient satisfaction

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
December 2011
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • American Society of Anesthesiology (ASA) physical status I and II
  • Four asymptomatic third molars indicated for removal

Exclusion Criteria

  • Clinical history or ECG evidence of:
  • cardiac dysrhythmia or heart block
  • ischemic heart disease
  • sleep apnea
  • impaired liver, renal, or mental function
  • chronic sedative or analgesic use
  • allergies to any of the study drugs
  • history of pericoronal infection with third molars

Arms & Interventions

Dex plus midazolam

Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg i.v.

Intervention: Dexmedetomidine

Dex plus midazolam

Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg i.v.

Intervention: Midazolam

Dex plus midazolam and ketamine

Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg and 0.25 mg/kg ketamine i.v.

Intervention: Dexmedetomidine

Dex plus midazolam and ketamine

Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg and 0.25 mg/kg ketamine i.v.

Intervention: Midazolam

Dex plus midazolam and ketamine

Dexmedetomidine loading dose of 0.4 mcg/kg followed by an infusion of 0.5 mcg/kg/hr plus midazolam 0.04 mg/kg and 0.25 mg/kg ketamine i.v.

Intervention: Ketamine

Outcomes

Primary Outcomes

Amnesia: Lack of Picture Recall Shown 15 Minutes Into Surgery

Time Frame: Day of Surgery prior to discharge

Lack of recall of picture shown at this time indicates presence of amnesia

Amnesia: Lack of Picture Recall Shown Prior to Sedation.

Time Frame: Day of surgery prior to discharge

Subjects were shown pictures of familiar objects prior to sedation, after the bolus dose of dexmedetomidine was administered, at 15 minutes and 30 minutes into the surgery and at the end of surgery. Subjects were shown a page containing multiple pictures to evaluate whether they could remember any of them. No recall demonstrating the presence of amnesia during that portion of the procedure. This process was repeated the day following surgery

Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown Following Dexmedetomidine Infusion Plus Midazolam.

Time Frame: One day after surgery

Inability to recall picture shown at this time indicates presence of amnesia on the day following surgery.

Amnesia: Lack of Picture Recall Shown 30 Minutes Into Surgery

Time Frame: Day of Surgery prior to discharge

Lack of recall of picture shown indicates presence of amnesia

Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown at Surgery End Time.

Time Frame: One day after surgery

Lack of recall of picture shown indicates presence of amnesia on day following surgery.

Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown Prior to Sedation.

Time Frame: One day after surgery

Lack of recall of picture shown indicates presence of amnesia the day following surgery.

Primary Title: Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown 30 Minutes Into Surgery.

Time Frame: One day after surgery

Lack of recall of picture shown indicates presence of amnesia on day following surgery.

Amnesia: Lack of Picture Recall at Surgery End Time.

Time Frame: Day of surgery prior to discharge

Lack of recall of picture shown indicates presence of amnesia

Amnesia: Lack of Picture Recall Following Dexmedetomidine Infusion Plus Midazolam.

Time Frame: Day of Surgery prior to discharge

Percentage of patients unable to recall picture

Amnesia: Lack of Recall One Day After Surgery of The Picture That Was Shown 15 Minutes Into Surgery.

Time Frame: One day after surgery

Lack of recall of picture demonstrates presence of amnesia on day following surgery

Secondary Outcomes

  • Respiratory Parameters: Oxyhemoglobin Saturation(During surgical procedure)
  • Respiratory Parameters: Respiratory Rate(During surgical procedure)
  • Mean Arterial Blood Pressure(During duration of surgery)
  • Heart Rate(Duration of surgery)
  • Patient Satisfaction With Sedation Technique(after completion of surgery (within 15 minutes))
  • Ramsey Sedation Scale Score(During surgical procedure)
  • Respiratory Parameters: End-tidal Carbon Dioxide(Duration of surgery)
  • Bispectral Index Score (BIS)(During surgery duration.)
  • Surgeon Satisfaction With Sedation Technique(After surgery completed: day of surgery, within 15 minutes)

Study Sites (1)

Loading locations...

Similar Trials